All News

Experts are skeptical of an executive order on preexisting conditions; study finds no differences in outcomes for newborns of women with coronavirus disease 2019 (COVID-19); COVID-19 cases on the rise in 4 states.

CMMI's Alexandra Chong, PhD, discusses COVID-19 related flexibilities under the Oncology Care Model, and a panel discusses its successor.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

A gradual acceptance among physicians has been observed in adopting quality care initiatives that provide cost-saving, improved patient experience in cancer care, noted Kerin Adelson, MD, of Smilow Cancer Hospital at Yale New Haven/Yale Cancer Center.

A study looking at older adults with chronic pain found no significant difference in cognitive performance when comparing them with matched patients who did not use medical cannabis.

Over a 4-year study period, the price for 30 tablets of preexposure prophylaxis (PrEP) medication increased more than 20%, potentially keeping the medication out of the hands of those most at risk for potentially contracting HIV.

Researchers hope that a more targeted retinoid acid X receptor compound could repair myelin without the adverse effects seen in every patient in this trial, which tested an already approved cancer drug.

Over 12.5 years of follow-up, close to 10% of participants developed incident heart failure in a recent study that investigated possible differentiation of cardiovascular (CV) risk factors and biomarkers based on sex.

In the real world, dupilumab has been as effective as the results in clinical trials, and patients are seeing low exacerbation rates, emergency department visits, and hospitalizations, explained Neal Jain, MD, FAAP, FAAAAI.

Testing for coronavirus disease 2019 (COVID-19) before procedures has become a fixture of City of Hope's efforts to protect patients with cancer and staff, noted Harlan Levine, MD, president of Strategy and Business Ventures at City of Hope.

Almost as fast as coronavirus disease 2019 (COVID-19) spread around the world, so has misinformation about the infectious disease. MJH Life Sciences™ will host a free webinar to get the facts from the experts.

Aligned with ASCO's Patient-Centered Oncology Payment model, Anthem has launched its value-based strategy called the oncology medical home, which seeks to promote quality metrics and improve outcome measures in cancer care.

A novel combination shows promise against advanced solid tumors, including triple-negative breast cancer, noted Timothy A. Yap, MBBS, PhD, FRCP, medical director of the Institute for Applied Cancer Science at MD Anderson Cancer Center.

This article was written by Maureen Hennessey, PhD, CPCC, CPHQ, senior vice president and director of Value Transformation for PRECISIONvalue.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Cases of coronavirus disease 2019 (COVID-19) surge in the Midwest; people of color express concerns about participating in COVID-19 vaccine trials; United Airlines will offer certain passengers COVID-19 testing in October.

This week, the top managed care news included a Supreme Court vacancy that could shape the fate of the Affordable Care Act; the pandemic’s effects on access to care; a look at the opportunities presented by the virtual format of Patient-Centered Oncology Care® 2020.

Following the onset of the coronavirus disease 2019 (COVID-19) pandemic, changes in pediatric asthma health care delivery patterns resulted in reduced hospital admissions and systemic steroid prescriptions in Philadelphia.

Higher body mass index based on genes is associated with a risk of developing rheumatoid arthritis, according to an analysis of genetic data published in Arthritis & Rheumatology.

Health workers providing care on the front lines of the coronavirus disease 2019 (COVID-19) pandemic were found to develop more sleep disturbances and have worse quality of sleep compared with non-health care professionals.

The results were shared as part of the MSVirtual2020: 8th Joint ACTRIMS-ECTRIMS Meeting, which is concluding Saturday with a special session about coronavirus disease 2019 (COVID-19).

Disease-modifying therapies (DMTs) are primarily effective through immunomodulation, in that they target relapse prevention, said Burcu Zeydan, MD, assistant professor of neurology, assistant professor of radiology, at Mayo Clinic.

Increasing their numbers could help to improve both trial enrollment diversity and improve patient outcomes, according to research published in Circulation: Heart Failure.

Progress within the adoption of clinical pathways, particularly in achieving standardization in cancer care, will be further discussed at Patient-Centered Oncology Care 2020®.

The announcement comes just 6 weeks before the Supreme Court is set to hear oral arguments in Texas v Azar, upon which the future of the Affordable Care Act (ACA)—which counts among its many provisions protection for patients with preexisting conditions—hinges, and which the administration is trying to get overturned.

By taking part in a coronavirus disease 2019 (COVID-19) vaccine trial, participants can provide their personalized experience, which may help protect future generations of similar race and socioeconomic background.

A poll lists top health issues in battleground states; no COVID-19 vaccine has been tested on children; researchers find a more contagious COVID-19 strain.

Vaccine safety and effectiveness are patients’ biggest concerns about a potential coronavirus disease 2019 (COVID-19) vaccine, says Maura Abbott, PhD, AOCNP, CPNP, RN, assistant professor of nursing at the Columbia University School of Nursing.

Patients with multiple sclerosis (MS) reported higher rates of harassment and criticism in the workplace than their healthy counterparts, even after informing employers and coworkers about their diagnosis.

Based on findings of the Business Group on Health’s 2021 Large Employers' Health Care Strategy and Plan Design Survey, employers have increased funding in virtual care and behavioral health amid the coronavirus disease pandemic.